• 1
    Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome: a clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 1965; 44: 187231.
  • 2
    Shearn MA. Sjögren's syndrome. Vol 2: major problems in internal medicine. Philadelphia: WB Saunders; 1971.
  • 3
    Daniels TE, Silverman S Jr, Michalski JP, Greenspan JS, Sylvester RA, Talal N. The oral component of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1975; 39: 87585.
  • 4
    Ohfuji T, Sjögren's Disease Research Committee. Review on research reports: annual report of the Ministry of Health and Welfare. Japan: Japanese Ministry of Health; 1977.
  • 5
    Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol Suppl 1986; 61: 267.
  • 6
    Manthorpe R, Frost-Larsen K, Isager H, Prause JU. Sjögren's syndrome: a review with emphasis on immunological features. Allergy 1981; 36: 13953.
  • 7
    Skopouli FN, Drosos AA, Papaioannou T, Moutsopoulos HM. Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol Suppl 1986; 61: 225.
  • 8
    Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum 1986; 29: 57785.
  • 9
    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 3407.
  • 10
    Fujibayashi T. Revised diagnostic criteria for Sjögren's syndrome. Rheumatology (Oxford) 2000; 24: 4218.
  • 11
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 12
    Daniels TE, Criswell LA, Shiboski C, Shiboski S, Lanfranchi H, Dong Y, et al, for the Sjögren's International Collaborative Clinical Alliance Research Groups. An early view of the international Sjögren's syndrome registry. Arthritis Rheum 2009; 61: 7114.
  • 13
    Classification and Response Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures. Development of classification and response criteria for rheumatic diseases [editorial]. Arthritis Rheum 2006; 55: 34852.
  • 14
    Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health 1984; 74: 97983.
  • 15
    Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H, et al, for the Sjögren's International Collaborative Clinical Alliance Research Groups. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum 2011; 63: 202130.
  • 16
    Feenstra RP, Tseng SC. Comparison of fluorescein and rose bengal staining. Ophthalmology 1992; 99: 60517.
  • 17
    Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. Am J Ophthalmol 2009; 149: 40515.
  • 18
    Chow S, Ruskey F. Drawing area-proportional Venn and Euler diagrams: 11th International Symposium on Graph Drawing, Perugia, Italy. Lect Notes Comput Sci 2003; 2912: 46677.
  • 19
    Goodman LA. Exploratory latent structure analysis using both identifiable and unidentifiable models. Biometrika 1974; 61: 21531.
  • 20
    Pepe MS, Janes H. Insights into latent class analysis of diagnostic test performance. Biostatistics 2007; 8: 47484.
  • 21
    Qu Y, Tan M, Kutner MH. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics 1996; 52: 797810.
  • 22
    Hartigan JA. Clustering algorithms. New York: John Wiley & Sons; 1975.
  • 23
    Baughman AL, Bisgard KM, Cortese MM, Thompson WW, Sanden GN, Strebel PM. Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin Vaccine Immunol 2008; 15: 10614.
  • 24
    See CW, Alemayehu W, Melese M, Zhou Z, Porco TC, Shiboski S, et al. How reliable are tests for trachoma? A latent class approach. Invest Ophthalmol Vis Sci 2011; 52: 61337.
  • 25
    Breiman L. Random forests. Mach Learn 2001; 45: 532.
  • 26
    Daniels T, Greenspan JS, Cox D, Criswell LA, DeSouza Y, Dong Y. Objective measures in Sjögren's syndrome associated with each other but not with sicca symptoms: analysis of 564 enrollees in the SICCA International Registry and Repository [abstract]. Arthritis Rheum 2007; 56 Suppl: S446.
  • 27
    Malladi AS, Sack KE, Shiboski S, Shiboski C, Baer AN, Banushree R, et al. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry. Arthritis Care Res (Hoboken) 2012. E-pub ahead of print.
  • 28
    Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009; 68: 13105.
  • 29
    Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011; 70: 13638.
  • 30
    Moutsopoulos HM, Webber BL, Vlagopoulos TP, Chused TM, Decker JL. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 1979; 66: 7336.